Graves病患者甲状腺全切除术后患者报告结局的变化
术后短期和长期的总症状负担、甲状腺症状评分和生活质量评分均较术前显著改善,提示手术可改善患者报告结局。
要点
- 甲状腺全切除术后短期和长期的患者报告结局均较术前显著改善。
- 甲状腺症状和生活质量评分在术后短期和长期均显著降低。
- 术前TSH中位数0.05,术后短期升至0.82,长期升至1.57。
核心结论
- Graves病患者甲状腺全切除术后生活质量和甲状腺特异性症状从术前基线到术后短期和长期均显著改善。
主要发现
- 总症状负担评分术前均值56.88,术后短期39.60,p<0.001。
- 甲状腺症状评分术前13.88,术后短期8.62,长期7.29,均p<0.05。
- 生活质量症状评分术前16.16,术后短期9.14,长期10.04,均p<0.05。
临床怎么用
- 研究结果可用于指导临床医生和Graves病患者对甲状腺全切除术后预期结局的咨询。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Graves' disease accounts for ∼80% of all cases of hyperthyroidism and is associated with significant morbidity and decreased quality of life. Understanding the association of total thyroidectomy with patient-reported quality-of-life and thyroid-specific symptoms is critical to shared decision-making and high-quality care. We estimate the change in patient-reported outcomes (PROs) before and after surgery for patients with Graves' disease to inform the expectations of patients and their physicians. Methods: PROs using the MD Anderson Symptom Inventory (MDASI) validated questionnaire were collected prospectively from adult patients with Graves' disease from January 1, 2015, to November 20, 2020, on a longitudinal basis. Survey responses were categorized as before surgery (≤120 days), short term after surgery (<30 days; ST), and long term after surgery (≥30 days; LT). Negative binomial regression was used to estimate the association of select covariates with PROs. Results: Eighty-five patients with Graves' disease were included. The majority were female (83.5%); 47.1% were non-Hispanic white and 35.3% were non-Hispanic black. The median thyrotropin (TSH) value before surgery was 0.05, which increased to 0.82 in ST and 1.57 in LT. In bivariate analysis, the Total Symptom Burden Score, a composite of all patient-reported burden, significantly reduced shortly after surgery (before surgery mean of 56.88 vs. ST 39.60, p < 0.001), demonstrating improvement in PROs. Furthermore, both the Thyroid Symptoms Score, including patient-reported thermoregulation, palpitations, and dysphagia, and the Quality-of-Life Symptom Score improved in ST and LT (thyroid symptoms, before surgery 13.88 vs. ST 8.62 and LT 7.29; quality of life, before surgery 16.16 vs. ST 9.14 and LT 10.04, all p < 0.05). After multivariate adjustment, the patient-reported burden in the Thyroid Symptom Score and the Quality-of-Life Symptom Score exhibited reduction in ST (thyroid symptoms, rate ratio [RR] 0.55, confidence interval [CI]: 0.42-0.72; quality of life, RR 0.57, CI: 0.40-0.81) and LT (thyroid symptoms, RR 0.59, CI: 0.44-0.79; quality of Life, RR 0.43, CI: 0.28-0.65). Conclusions: Quality of life and thyroid-specific symptoms of Graves' patients improved significantly from their baseline before surgery to both shortly after and longer after surgery. This work can be used to guide clinicians and patients with Graves' disease on the expected outcomes following total thyroidectomy.
引用
- Gunn AH, Frisco N, Thomas SM, et al. Patient-Reported Outcomes Following Total Thyroidectomy for Graves' Disease. Thyroid. 2021. PMID: 34663089. doi:10.1089/thy.2021.0285
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。